These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16205927)

  • 1. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?
    Musabak U; Pay S; Erdem H; Simsek I; Pekel A; Dinc A; Sengul A
    Rheumatol Int; 2006 Apr; 26(6):545-50. PubMed ID: 16205927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
    Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D; Keskin G; Inal A; Ozışık L
    Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
    Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
    Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM; Bozkurt M; Uçmak D; Yüksel H; Uçak H; Sula B; Gürsel Özkurt Z; Yildiz M; Akdeniz D; Arica M
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.
    Djaballah-Ider F; Djeraba Z; Chemli M; Dammene-Debbihe N; Lounis D; Belguendouz H; Medour Y; Chaib S; Touil-Boukoffa C
    Inflammopharmacology; 2018 Jun; 26(3):725-735. PubMed ID: 29600486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
    Frassanito MA; Dammacco R; Cafforio P; Dammacco F
    Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of serum interleukin-20 levels in patients with Behçet's disease.
    Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
    Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?
    Pay S; Simsek I; Erdem H; Pekel A; Musabak U; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S34-40. PubMed ID: 17949549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.